This video explains the workings of the Endocannibanoid system.

We are building a culture of scientific inquiry, invention and collaboration.


All mammals have a biological and neurological system specifically tasked to receive and process nutritional cannabinoids. The endocannabinoid system (ECS) is involved in a variety of physiological processes including appetite, pain-sensation, nausea, mood and memory without some of the side effects that are commonly associated with current treatments for animal health.

Cannabinoids such as Cannabidiol (CBD) and Tetrahydrocannabinol (THC) are naturally occurring compounds present in trace amounts in several plants, most notably (though not exclusively) in cannabis. Cannabinoids have been cultivated for thousands of years, in part because they uniquely interact with the ECS.

All mammals, including cats and dogs, can produce their own cannabinoids to interact and influence the encocannabinoid system, to create desired therapeutic effects. Through the research and development of the phytocannabinoids found in cannabis, we hope to be able to provide standardised and scientifically validated methods of delivery so owners and veterinarians can safely administer this medicine to their pets.


Much like the Human Endocannabinoid system, the ECS has two kinds of receptors, CB1 and CB2. CB1 receptors are mostly in the brain and the nervous system and CB2 receptors are mostly in peripheral organs, especially immune cells. We need cannabinoids to communicate with these receptors and keep the body in a state of homeostasis for optimal health.

Now is the time to push towards innovation in the animal health industry.


There are a number of products in our pipeline for development.

Please contact us for an investor presentation to find out what we are presently developing.